← back to search

Kangbo Huang

Sun Yat-sen University · CN
Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research interests include Renal cell carcinoma treatment, Cancer-related molecular mechanisms research, Genital Health and Disease, and MicroRNA in disease regulation.
h-index
13
citations
637
works
28
NIH funding
primary concept
email

Recent publications

A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma
Nature Communications 2024cited by 17position: firstdoi
Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8 <sup>+</sup> T cell metabolic fitness and function in tumors
Science Immunology 2023cited by 85position: middledoi
Exosomal circSPIRE1 mediates glycosylation of E-cadherin to suppress metastasis of renal cell carcinoma
Oncogene 2023cited by 52position: middledoi
EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1
Advanced Science 2023cited by 45position: middledoi
Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study
The Lancet Digital Health 2023cited by 43position: middledoi
Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor–based combination therapy
Cancer 2023cited by 15position: middledoi
Extracellular Vesicle-Mediated Transfer of LncRNA <i>IGFL2-AS1</i> Confers Sunitinib Resistance in Renal Cell Carcinoma
Cancer Research 2022cited by 81position: middledoi
Chitosan‐Gelatin‐EGCG Nanoparticle‐Meditated LncRNA TMEM44‐AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5‐FU Resistance in Gastric Cancer
Advanced Science 2022cited by 76position: middledoi
Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma
European Urology 2022cited by 55position: middledoi
Circular RNA circSNX6 promotes sunitinib resistance in renal cell carcinoma through the miR-1184/GPCPD1/ lysophosphatidic acid axis
Cancer Letters 2021cited by 66position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Guannan Shu · Guangzhou Women and Children Medical Center5 papers (2021–2023)Yihui Pan · Soochow University5 papers (2021–2023)Jiaxing Zhang · Chinese Academy of Medical Sciences & Peking Union Medical College5 papers (2021–2023)Junjie Cen · Sun Yat-sen University4 papers (2022–2023)Jun Lü · Zhejiang Chinese Medical University4 papers (2021–2023)Hui Han · Shanxi Medical University4 papers (2021–2023)Mi Zhou · Army Medical University4 papers (2021–2023)Xuanxuan Lu · Hong Kong Polytechnic University3 papers (2022–2023)Jiaqi Dong · Shanghai Jiao Tong University3 papers (2022–2023)Jinhuan Wei · Hebei Medical University3 papers (2021–2023)Zhenhua Chen · Chimie ParisTech3 papers (2021–2023)Junhang Luo · Sun Yat-sen University3 papers (2021–2023)Quanhui Xu · The First Affiliated Hospital, Sun Yat-sen University2 papers (2022–2023)Junhang Luo · Sun Yat-sen University2 papers (2022–2023)Zhousan Zheng · Sun Yat-sen University2 papers (2021–2022)Zihao Feng · East China University of Technology2 papers (2021–2023)Wei Chen · National Health Research Institutes2 papers (2021–2023)Huashan Liu · Sun Yat-sen University1 papers (2023–2023)Liangmin Fu · Central South University1 papers (2023–2023)Chengpeng Gui · First Affiliated Hospital of Guangzhou Medical University1 papers (2023–2023)